CJC-1295 w/ DAC – 5mg

CJC-1295 (w/ DAC) – 5mg Research Compound

CJC-1295 (with Drug Affinity Complex – DAC) is a growth hormone–releasing hormone (GHRH) analog selected for laboratory investigation into sustained growth hormone–associated signaling pathways and hypothalamic–pituitary regulatory mechanisms. The DAC modification is studied for its extended binding characteristics within controlled research environments examining receptor-mediated endocrine communication.

Within structured scientific models, researchers evaluate prolonged growth hormone pathway dynamics, downstream metabolic signaling processes, and broader neuroendocrine regulatory frameworks. Investigation remains preliminary, model-specific, and highly dependent on experimental design and study conditions.

Research Applications

• Investigation of sustained growth hormone–associated signaling pathways

• Evaluation of hypothalamic–pituitary regulatory mechanisms

• Study of receptor-binding dynamics and endocrine communication

• Analysis of downstream metabolic signaling processes

• Inclusion in endocrine and metabolic research models

For research use only. Not for human consumption.
This product is not approved by the U.S. Food and Drug Administration and is supplied strictly for laboratory, educational, and research purposes.